» Articles » PMID: 26202163

The Number of Discharge Medications Predicts Thirty-day Hospital Readmission: a Cohort Study

Overview
Publisher Biomed Central
Specialty Health Services
Date 2015 Jul 24
PMID 26202163
Citations 36
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Hospital readmission occurs often and is difficult to predict. Polypharmacy has been identified as a potential risk factor for hospital readmission. However, the overall impact of the number of discharge medications on hospital readmission is still undefined.

Methods: To determine whether the number of discharge medications is predictive of thirty-day readmission using a retrospective cohort study design performed at Barnes-Jewish Hospital from January 15, 2013 to May 9, 2013. The primary outcome assessed was thirty-day hospital readmission. We also assessed potential predictors of thirty-day readmission to include the number of discharge medications.

Results: The final cohort had 5507 patients of which 1147 (20.8 %) were readmitted within thirty days of their hospital discharge date. The number of discharge medications was significantly greater for patients having a thirty-day readmission compared to those without a thirty-day readmission (7.2 ± 4.1 medications [7.0 medications (4.0 medications, 10.0 medications)] versus 6.0 ± 3.9 medications [6.0 medications (3.0 medications, 9.0 medications)]; P < 0.001). There was a statistically significant association between increasing numbers of discharge medications and the prevalence of thirty-day hospital readmission (P < 0.001). Multiple logistic regression identified more than six discharge medications to be independently associated with thirty-day readmission (OR, 1.26; 95 % CI, 1.17-1.36; P = 0.003). Other independent predictors of thirty-day readmission were: more than one emergency department visit in the previous six months, a minimum hemoglobin value less than or equal to 9 g/dL, presence of congestive heart failure, peripheral vascular disease, cirrhosis, and metastatic cancer. A risk score for thirty-day readmission derived from the logistic regression model had good predictive accuracy (AUROC = 0.661 [95 % CI, 0.643-0.679]).

Conclusions: The number of discharge medications is associated with the prevalence of thirty-day hospital readmission. A risk score, that includes the number of discharge medications, accurately predicts patients at risk for thirty-day readmission. Our findings suggest that relatively simple and accessible parameters can identify patients at high risk for hospital readmission potentially distinguishing such individuals for interventions to minimize readmissions.

Citing Articles

Follow-up and reasons for extended-release naltrexone discontinuation for alcohol use disorder after hospital initiation.

Martin M, Seraydarian M, Gasper J, DeFries T BMJ Open Qual. 2024; 13(4.

PMID: 39653511 PMC: 11628980. DOI: 10.1136/bmjoq-2024-003113.


Pathophysiological Features in Electronic Medical Records Sustain Model Performance under Temporal Dataset Shift.

Brosula R, Corbin C, Chen J AMIA Jt Summits Transl Sci Proc. 2024; 2024:95-104.

PMID: 38827052 PMC: 11141811.


Risk factors for medication-related short-term readmissions in adults - a scoping review.

Schonenberger N, Meyer-Massetti C BMC Health Serv Res. 2023; 23(1):1037.

PMID: 37770912 PMC: 10536731. DOI: 10.1186/s12913-023-10028-2.


Identifying older adults at increased risk of medication-related readmission to hospital within 30 days of discharge: development and validation of a risk assessment tool.

Glans M, Kempen T, Jakobsson U, Kragh Ekstam A, Bondesson A, Midlov P BMJ Open. 2023; 13(8):e070559.

PMID: 37536970 PMC: 10401249. DOI: 10.1136/bmjopen-2022-070559.


Use of pharmacy services in community-dwelling middle-aged and older adults; findings from The Irish Longitudinal Study on Ageing (TILDA).

Murry L, Flood M, Holton A, Kenny R, Moriarty F Explor Res Clin Soc Pharm. 2023; 10:100265.

PMID: 37181502 PMC: 10173775. DOI: 10.1016/j.rcsop.2023.100265.


References
1.
Kocher R, Adashi E . Hospital readmissions and the Affordable Care Act: paying for coordinated quality care. JAMA. 2011; 306(16):1794-5. DOI: 10.1001/jama.2011.1561. View

2.
Walker P, Bernstein S, Tucker Jones J, Piersma J, Kim H, Regal R . Impact of a pharmacist-facilitated hospital discharge program: a quasi-experimental study. Arch Intern Med. 2009; 169(21):2003-10. DOI: 10.1001/archinternmed.2009.398. View

3.
Zhang C, Zhang L, Huang L, Luo R, Wen J . Clinical pharmacists on medical care of pediatric inpatients: a single-center randomized controlled trial. PLoS One. 2012; 7(1):e30856. PMC: 3264625. DOI: 10.1371/journal.pone.0030856. View

4.
Fontanarosa P, McNutt R . Revisiting hospital readmissions. JAMA. 2013; 309(4):398-400. DOI: 10.1001/jama.2013.42. View

5.
Kociol R, Lopes R, Clare R, Thomas L, Mehta R, Kaul P . International variation in and factors associated with hospital readmission after myocardial infarction. JAMA. 2012; 307(1):66-74. DOI: 10.1001/jama.2011.1926. View